🤖 Introducing Owkin K: A community of specialized AI agents. Their mission? To work with our data scientists on decoding the complexities of the immune system. We are excited to continue our ambition for the future of drug discovery, development and diagnostics. 🚀 Watch the video to find out how Owkin will use agentic AI in the future. #ai #agenticai
Owkin
Biotechnology Research
New York, NY 41,057 followers
We use AI to find the right treatment for every patient.
About us
Owkin is an AI biotechnology company that uses AI to find the right treatment for every patient. We combine the best of human and artificial intelligence to answer the research questions shared by biopharma and academic researchers. By closing the translational gap between complex biology and new treatments, we bring new diagnostics and drugs to patients sooner. We use AI to identify new treatments, de-risk and accelerate clinical trials and build diagnostic tools. Using federated learning, a pioneering collaborative AI framework, Owkin enables partners to unlock valuable insights from siloed datasets while protecting patient privacy and securing proprietary data. Owkin was co-founded by Thomas Clozel MD, a former assistant professor in clinical onco-hematology, and Gilles Wainrib, a pioneer in the field of machine learning in biology, in 2016. Owkin has raised over $300 million and became a unicorn through investments from leading biopharma companies (Sanofi and BMS) and venture funds (Fidelity, GV and BPI, among others).
- Website
-
https://www.owkin.com
External link for Owkin
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- New York, NY
- Type
- Privately Held
- Founded
- 2016
- Specialties
- artificial intelligence, omics technology, oncology, drug discovery, medical research, biomedical images, real-world data, real world evidence, radiology, clinical data, federated learning, covariate adjustment, clinical tools, digital pathology, healthcare, diagnostic solutions, biomarkers, precision medicine, and data science
Locations
Employees at Owkin
-
Jean-Philippe Vert
Chief R&D at Owkin / Co-founder at Bioptimus / Use AI to unravel biology and find the right treatment for every patient
-
Helen Burns
Freelance Resourcing Director | Talent Acquisition Leader | Coach delivering impact through change | Flow Game Host
-
Michaël Auffret
-
Rodney Hawkins
Updates
-
🇮🇹 It’s almost time for the European Congress of Pathology (ECP) by European Society of Pathology - September 7th to 11th, 2024. Join us in Florence, Italy, at Booth #88 to learn how Owkin is changing healthcare using AI. Book a meeting with us https://lnkd.in/edf8CX8J
-
-
🎬 Watch MSIntuit® CRC in action — discover its capabilities, features and functionalities, with comprehensive insights for microsatellite instability (MSI) testing. MSIntuit® CRC is a CE-marked AI diagnostic that provides a MSI prescreen approach with digital pathology. Learn more about MSIntuit CRC: https://lnkd.in/gy5ubAZs
-
Geneviève Robin, our Director of Exploratory Research Programs, has been elected as Adjunct Secretary on the board of Société Française de Statistiques (SFdS). The SFdS is dedicated to promoting and advancing the field of statistics. This appointment reflects Owkin's commitment and expertise in the field. Congratulations Geneviève! Learn more about SFdS: https://www.sfds.asso.fr/
-
-
🎧 Dr. Félix Balazard, our Director of Optimized Development Solutions, discusses the use of federated external control arms (ECA) and covariate adjustment in clinical trials on the latest episode of The Medical AI Podcast, with host Dr. Felix Beacher. Tune in to learn how AI is transforming clinical trials for greater efficiency and higher probability of success. https://lnkd.in/eEjQwx6H #federatedlearning #AI #clinicaltrials
-
-
In this edition of our #OwkinSummer series, we’re celebrating the #OwLympics! 🏃♀️🥇🏃 We challenged our Owkinautes to a series of fun and competitive online and in-person activities. Each week featured a new set of games, including photo contests, scavenger hunts, running, speed typing, and more, sparking both the physical and creative sides of our Owkinautes. Congrats to our champions! 🏆 Thank you for the awesome energy—can't wait for the next season to come. #LifeAtOwkin
-
-
🎥 Dr. Meriem Sefta, our Chief Diagnostics Officer, discusses partnerships between AI diagnostic biotech and the pharmaceutical industry in our recent STAT webinar “Is This the Era of AI Diagnostics?”. Watch the webinar: https://lnkd.in/eY_BW5qp
-
We’re adding gold to our medal count! Owkin proudly took home three awards from The Stevie® Awards for "Bringing AI Cancer Testing to Patients with MSIntuit® CRC”: 🏅 Gold: Technology Breakthrough of the Year in AI 🏅 Gold: Technology Breakthrough of the Year in Healthcare Technology 🏆 Grand trophy: Highest-Rated Nomination of the Year This recognition reinforces our dedication to advancing healthcare through innovative AI and data-driven solutions. Learn how MSIntuit® CRC tackles the colorectal cancer screening challenge and improves access to immunotherapy through MSI testing: https://lnkd.in/gy5ubAZs #TheStevieAwards #AI #diagnostics
-
🇫🇮 We are excited to announce our collaboration with Finnish Biobanks FINBB to access a collection of 11 million samples from their biobanks in Finland. Owkin will bring its world-class data access and AI to the forefront of drug discovery and development, analyzing multimodal patient data in a privacy-enhanced way to advance medical research. Read more: https://lnkd.in/eujGUihT
Owkin and Finnish Biobanks collaborate to advance medical research - Owkin
owkin.com